ChemBK
  • Home
  • Product Category

Benzamide, 4-(hydroxymethyl)-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-

Benzamide, 4-(hydroxymethyl)-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-

CAS: 1807608-52-1

Molecular Formula: C28H22F3N7O2

  1. Home
  2. Product Category
  3. Benzamide, 4-(hydroxymethyl)-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-

Benzamide, 4-(hydroxymethyl)-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]- - Names and Identifiers

Name Benzamide, 4-(hydroxymethyl)-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-
Synonyms Benzamide, 4-(hydroxymethyl)-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-
Nilotinib Impurity 47
CAS 1807608-52-1

Benzamide, 4-(hydroxymethyl)-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]- - Physico-chemical Properties

Molecular FormulaC28H22F3N7O2
Molar Mass545.52
Benzamide, 4-(hydroxymethyl)-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-
Supplier List
Hubei YoungXin Pharmaceutical Tech Co.,Ltd.
Product Name: Nilotinib Impurity 47 Request for quotation
CAS: 1807608-52-1
Tel: 0714-3999186
Email: 2853786052@qq.com
Mobile: 86+15671228036
QQ: 2853786052 Click to send a QQ message
Wechat: 15671228036
Hubei YoungXin Pharmaceutical Tech Co.,Ltd.
Product Name: Nilotinib Impurity 47 Request for quotation
CAS: 1807608-52-1
Tel: 0714-3999186
Email: 2853786052@qq.com
Mobile: 86+15671228036
QQ: 2853786052 Click to send a QQ message
Wechat: 15671228036
View History
Benzamide, 4-(hydroxymethyl)-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-
  • Home
  • Product Category

© 2015, 2023 ChemBK.com All Rights Reserved | Build: 20230617001